During the last session, Processa Pharmaceuticals Inc (NASDAQ:PCSA)’s traded shares were 1.89 million, with the beta value of the company hitting 1.33. At the end of the trading day, the stock’s price was $0.27, reflecting an intraday gain of 6.37% or $0.01. The 52-week high for the PCSA share is $3.10, that puts it down -1048.15 from that peak though still a striking 44.44% gain since the share price plummeted to a 52-week low of $0.15. The company’s market capitalization is $3.25M, and the average trade volume was 2.42 million shares over the past three months.

Processa Pharmaceuticals Inc (PCSA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.00. PCSA has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.

Processa Pharmaceuticals Inc (NASDAQ:PCSA) trade information

Processa Pharmaceuticals Inc (PCSA) registered a 6.37% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 6.37% in intraday trading to $0.27, hitting a weekly high. The stock’s 5-day price performance is 9.56%, and it has moved by 14.55% in 30 days. Based on these gigs, the overall price performance for the year is -88.34%.

The consensus price target of analysts on Wall Street is $9, which implies an increase of 97.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $9 and $9 respectively. As a result, PCSA is trading at a discount of -3233.33% off the target high and -3233.33% off the low.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 22.65%. While earnings are projected to return 75.19% in 2025, the next five years will return 42.65% per annum.

PCSA Dividends

Processa Pharmaceuticals Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Also, the Mutual Funds coming in first place with the largest holdings of Processa Pharmaceuticals Inc (PCSA) shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . Data provided on Mar 31, 2025 indicates that Fidelity Concord Street Trust-Fidelity Extended Market Index Fund owns about 29.24 shares. This amounts to just over 0.55 percent of the company’s overall shares, with a $8012.0 market value. The same data shows that the other fund manager holds slightly less at 24.43, or about 0.46% of the stock, which is worth about $6694.0.